Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-11-27
1993-01-12
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514866, 514884, 514946, 514947, 514950, 514951, 514952, 514943, 514970, A61K 3702, A61K 3726, A61K 3166, A61K 910
Patent
active
051790793
ABSTRACT:
The systemic absorption after intranasal administration of certain drugs, in particular pharmacologically active polypeptides is enhanced in the presence of a phospholipid, such as a phosphatidylcholine (a lecithin), preferably admixed with a vegetable oil.
REFERENCES:
patent: 3594476 (1971-07-01), Merrill
patent: 3869549 (1975-03-01), Geller
patent: 4153689 (1979-05-01), Hirai et al.
patent: 4476116 (1984-10-01), Anik
patent: 4548922 (1985-10-01), Carey et al.
patent: 4614730 (1986-09-01), Hansen et al.
patent: 4617149 (1986-10-01), Dimarchi et al.
patent: 4944948 (1990-07-01), Uster et al.
patent: 5023087 (1991-06-01), Yau-Young
Robert Salzman et al., "Intranasal Aerosolized Insulin", The New England Journal of Medicine, Apr. 25, 312:1078-1084, (1985).
Robert E. Stratford, Jr. et al., "Aminopeptidase activity in homogenates of various absorptive mucosae in the albino rabbit: implications in peptide delivery", International Journal of Pharm. 30 (1986) pp. 73-82.
Fritz Paltauf, "Chemical Synthesis of Ester Lipids", Academic Press, Inc. (1983) pp. 520-526.
E. Cubero Robles et al., "Synthesis of Lecithins by Acylation of O-(in-Glycero-3-Phosphoryl)Choline with Fatty Acid Anhydride", Biochemica et Biophysica Acta; 187(1969) pp. 520-526.
Lisbeth Illum, "Drug delivery systems for nasal application," Arch. Pharm. Chemi. 94, (1987), pp. 127-135.
Derwent Abstract No. C84-003184 of Jp58201712, Nov. 1983, English language abstract.
The Merck Index, 9th edition, Merck and Co. Inc., Rahway, N.J., (1976) entry Nos. 4277, 4815, 4859 on pp. 573, 652 & 659.
Hansen Philip E.
Sorensen Anders R.
Griffin Ronald W.
Novo Nordisk A S
LandOfFree
Nasal formulation and intranasal administration therewith does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nasal formulation and intranasal administration therewith, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nasal formulation and intranasal administration therewith will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1220234